Rotageek provides cloud-based, data-driven scheduling technology to help multi-site businesses more accurately predict customer demand, schedule staff and improve operational efficiency.
Leading brands, including high street names like The Perfume Shop, Dune, Pets at Home and O2, already use Rotageek’s intelligent software across their UK stores to more effectively schedule staff, provide better cover for shifts and to manage leave during busy periods.
Led by Mobeus, the investment round totalled £4m. With the investment, Rotageek will continue to develop its advanced data-driven solutions, and recruit experienced specialists in development and customer service. At completion, the board will be strengthened by the appointment of Stuart Dawson, who will join as non-executive chairman. Dawson has a track record of scaling fast growing software businesses and was previously Managing Director-ABS Division of IRIS Software.
Greg Blin, who led the deal for Mobeus, will also join the board. Blin comments, “We identified the workforce management sector as a significant and growing, yet highly fragmented market that has had little innovation. Many businesses still adopt labour-intensive, time-consuming, manual processes, which do not provide staffing metrics. Rotageek provides a technology-driven solution with the potential to disrupt that market.”
Chris McCullough, Rotageek CEO, says, “Rotageek has seen significant growth over the past few years, all thanks to our team’s hard work, our clients’ collaboration, and our investors’ continued dedication and support. This investment round, led by Mobeus, will help us continue to invest in our tech, our talent, and our business development. Everyone at Rotageek is passionate about creating a step change in scheduling to improve not only how businesses run their operations, but to also positively and significantly impact the lives of shift-based employees. We are excited to have Mobeus join our team and look forward to delivering ever better scheduling for more clients.”
CDD for Apposite Capital's acquisition of 1MED
Apposite Capital, a healthcare specialist private equity investor, has acquired 1MED, a fast-growing Contract Research Organisation (“CRO”) for clinical and ...
CDD for Stuart Turner's acquisition of pressuri...
Stuart Turner, the manufacturer of water boosting pumps and systems, has acquired pressurisation and HVAC specialist Mikrofill Systems. The transaction has b...